Unlike standard prescription drugs, compounded medications are not reviewed or approved by the FDA, meaning the agency does not assess their safety, effectiveness, or quality before they are distributed
NICE guidance (TA875) supports the use of semaglutide for weight management in specific circumstances through specialist weight management services, but combination pharmacotherapy requires careful justification
5-7 Multiple studies have linked gut dysbiosis a change or imbalance in the diversity, composition and functions of the microbiota to reduced GLP-1 levels
Primary and Secondary Study Endpoints The primary endpoint was the percentage change in body weight from baseline to week 12
Furthermore, it has anti-inflammatory properties
The following two graphs show the effects of shorter periods between doses, using half the indicated dose